
Outpatient treatment is primarily based on patient-specific factors, whereas oseltamivir remains the therapy of choice for inpatient settings.
Outpatient treatment is primarily based on patient-specific factors, whereas oseltamivir remains the therapy of choice for inpatient settings.
This study highlights one benefit of the integrated health system specialty pharmacy model for patients who are prescribed acalabrutinib.
Key questions to ask when deciding whether compounding facilities are the right fit.
Corticosteroids are first-line therapy for gaining platelet stability but should only be used short term.
Panelists discuss pharmacist involvement in effective management, including disease burden and quality of life.
Many health care systems use these products to provide similar but cheaper clinical outcomes.
Predictably, patients in underserved rural, urban communities will face challenges gaining access to approved study sites.
Pharmacists can help by preventing and treating opioid use disorder and overdoses.